263 related articles for article (PubMed ID: 24327926)
1. Molecular mechanisms of treadmill therapy on neuromuscular atrophy induced via botulinum toxin A.
Tsai SW; Chen HL; Chang YC; Chen CM
Neural Plast; 2013; 2013():593271. PubMed ID: 24327926
[TBL] [Abstract][Full Text] [Related]
2. Treadmill running upregulates the expression of acetylcholine receptor in rat gastrocnemius following botulinum toxin A injection.
Tsai SW; Tung YT; Chen HL; Shen CJ; Chuang CH; Tang TY; Chen CM
J Orthop Res; 2013 Jan; 31(1):125-31. PubMed ID: 22733692
[TBL] [Abstract][Full Text] [Related]
3. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
4. Effects of treadmill running on rat gastrocnemius function following botulinum toxin A injection.
Tsai SW; Chen CJ; Chen HL; Chen CM; Chang YY
J Orthop Res; 2012 Feb; 30(2):319-24. PubMed ID: 21815203
[TBL] [Abstract][Full Text] [Related]
5. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
6. Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.
Baskaran P; Lehmann TE; Topchiy E; Thirunavukkarasu N; Cai S; Singh BR; Deshpande S; Thyagarajan B
Toxicon; 2013 Sep; 72():71-80. PubMed ID: 23810945
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
9. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
Williams SA; Reid S; Elliott C; Shipman P; Valentine J
Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
[TBL] [Abstract][Full Text] [Related]
10. Evidence for central antispastic effect of botulinum toxin type A.
Matak I
Br J Pharmacol; 2020 Jan; 177(1):65-76. PubMed ID: 31444910
[TBL] [Abstract][Full Text] [Related]
11. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of nAChR, SNAP-25 and GAP-43 in skeletal muscles following botulinum toxin A injection: a study in rats.
Ma J; Shen J; Lee CA; Elsaidi GA; Smith TL; Walker FO; Rushing JT; Tan KH; Koman LA; Smith BP
J Orthop Res; 2005 Mar; 23(2):302-9. PubMed ID: 15734240
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
14. Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice.
Fujikawa R; Muroi Y; Unno T; Ishii T
J Toxicol Sci; 2010 Dec; 35(6):795-805. PubMed ID: 21139329
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
Chen YT; Zhang C; Liu Y; Magat E; Verduzco-Gutierrez M; Francisco GE; Zhou P; Zhang Y; Li S
Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751970
[TBL] [Abstract][Full Text] [Related]
16. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
[TBL] [Abstract][Full Text] [Related]
17. Interaction between gastrocnemius muscle weakness and moderate exercise deteriorates joint integrity in rat knee.
Ozawa J; Kaneguchi A; Tanaka R; Kawamata S; Kurose T; Moriyama H; Kito N; Kawaguchi N; Matsuura N
Scand J Med Sci Sports; 2015 Feb; 25(1):e11-9. PubMed ID: 24588549
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of independent versus integrated effects of reciprocal electrical stimulation and botulinum toxin-A on dynamic limits of postural stability and ankle kinematics in spastic diplegia: a single-blinded randomized trial.
Elnaggar RK; Elbanna MF
Eur J Phys Rehabil Med; 2019 Apr; 55(2):241-249. PubMed ID: 29904047
[TBL] [Abstract][Full Text] [Related]
19. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a.
Thyagarajan B; Krivitskaya N; Potian JG; Hognason K; Garcia CC; McArdle JJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):361-71. PubMed ID: 19654265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
